Company timeline
올리패스
Sept. 10, 2026 — Oct. 12, 2026 · 2 stories
DART corporate ID 01070149
Filing dates come from the original receipt records. Story dates show when we reported them. The sequence groups our coverage of one company; it does not imply causes or outcomes.
Follow the filing dates
· Filed
Korean filing: [기재정정]회생절차개시결정
Olipass enters court receivership after Suwon court ruling
The Suwon Rehabilitation Court ordered the start of rehabilitation proceedings for the Kosdaq-listed biotech firm on June 5, appointing CEO Kim Tae-hyun as administrator.
Our story
· Filed
Korean filing: [기재정정]회생절차개시결정
Olipass wins court-led rehabilitation as creditor deadlines slip to November
A Suwon court opened rehabilitation proceedings for the Kosdaq-listed RNA drug developer in June, and the company has extended the period for examining creditors' claims to Nov. 6.
Our story
Our filing-based coverage over the past 180 days. This is not a complete list of disclosures or events; an announced contract or plan does not mean it has been completed.